 |
Data=Korea Health Industry Promotion Agency |
|
Sales of pharmaceutical and health functional food businesses among the bio-health industries increased, but sales of the medical device industry fell sharply.
According to the results of the bio-health industry survey conducted by the Korea Health Industry Promotion Agency, the domestic bio-health industry's sales amounted to 155.8785 trillion won in 2023, up 0.8% from the previous year. Sales growth, which increased 6.9% from 144.71 trillion won in 2021 to 154.6931 trillion won the following year, slowed down.
The largest pharmaceutical sector among the bio-health industries had sales of 53.808 trillion won in 2023, up 6.1% from a year ago.
 |
Data=Korea Health Industry Promotion Agency |
|
Sales of health functional foods jumped 10.3% from 20.4002 trillion won in 2022 to 22.51 trillion won in 2023. When dividing sales by function, sales of nutrient functional foods accounted for the majority of the total with 12.152 trillion won (53.4 percent), while physiologically active functional foods accounted for 6.2889 trillion won (27.9 percent) and 4.206 trillion won (18.7 percent) of disease-reducing functional foods. However, the number of industrial workers increased from 53,035 in 2021 to 55,506 in the following year, before plunging 18.9% in a year to 45,031 in 2023. In addition, R&D expenses also decreased to 356.7 billion won in 2021, 353.2 billion won in 2022, and 309.4 billion won in 2023.
 |
Data=Korea Health Industry Promotion Agency |
|
In the case of the medical device industry, sales fell from 45.6 trillion won in 2022 to 37.9586 trillion won (-15.7%) in 2023.
Meanwhile, sales in the cosmetics industry fell 6.8% year-on-year in 2022 (39.2395 trillion won) and increased 7.9% to 42.329 trillion won in 2023.
This article was translated by Naver AI translator.